Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in China. This nod comes just weeks after the company won approval from China’s National Medical Products Administration for the Genesis robotic magnetic navigation (RNM) system. St. Louis, Missouri-based Stereotaxis aims to accelerate access to its minimally invasive technology in China. […]
Stereotaxis
Stereotaxis surgical robot earns regulatory nod in China
Stereotaxis (NYSE:STXS) announced today that its Genesis surgical robot received regulatory approval in China. China’s National Medical Products Administration granted approval for the Genesis robotic magnetic navigation (RNM) system. Genesis delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias. The system utilizes smaller magnets that rotate along their center of […]
Hospital in Portugal adopts Stereotaxis surgical robot
Stereotaxis (NYSE:STXS) announced today that physicians at a hospital in Portugal successfully treated the first patients using its Genesis system. Physicians at the Hospital da Luz in Lisbon treated patients using the advanced Genesis robotic magnetic navigation (RMN) system. This marks the second major hospital adoption for Genesis this month, following treatments at the University […]
Kansas hospital begins robotic heart program with Stereotaxis surgical robot
Stereotaxis (NYSE:STXS) announced today that physicians at the University of Kansas Health System successfully treated the first patients with its Genesis system. The first use of the Genesis robotic magnetic navigation (RMN) system comes as part of a robotic heart program at the health system. Genesis delivers the benefits of robotic precision and safety to […]
Stereotaxis wins CE mark for next-gen surgical robot, submits to FDA
Stereotaxis (NYSE:STXS) announced that it obtained CE mark in Europe and submitted an FDA 510(k) application for its next-generation surgical robot. The GenesisX system is the latest iteration of Stereotaxis’ Genesis robotic magnetic navigation (RMN) system. It builds upon the company’s technology while reducing the complexities and barriers to hospital adoption. Stereotaxis said in a news […]
Stereotaxis adds former Luminex CEO to its board
Surgical robotic technology developer Stereotaxis (NYSE:STXS) announced that it appointed Nachum “Homi” Shamir to its board of directors. Shamir most recently served as chair and CEO at Luminex. He held that post from 2014 until the company’s $1.8 billion sale to DiaSorin in 2021. Before Luminex, Shamir served as president and CEO at Given Imaging. […]
Stereotaxis wins updated CE mark for all devices available in Europe
Stereotaxis (NYSE:STXS) announced today that it received CE mark for its devices in Europe under new European Medical Device Regulation (EU MDR) framework. Recertification under MDR covers all Stereotaxis devices available in Europe. In 2021, EU MDR replaced the EU Medical Device Directive (MDD) with more stringent requirements on the companies that perform the audits […]
Stereotaxis establishes first robotic heart procedure program in Italy
Stereotaxis (NYSE:STXS) announced today that a hospital in Italy established the first robotic cardiac heart program in the region. Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, established the program. Now, doctors there can treat patients with heart rhythm disorders using robotic ablation procedures. The hospital becomes the first in […]
Stereotaxis submits Magic ablation catheter for U.S., European approval
Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. According to a news release, the […]
10 surgical robotics companies you need to know
The surgical robotics space saw a major shakeup last year. “Robotics is hard. Robotics in healthcare is hard.” Hani Abouhalka, Johnson & Johnson’s company group chair for Robotics & Digital, said those words at our DeviceTalks West event in California in October. It pretty much sums up the situation for medtech companies large and small […]
First cases performed in Kentucky with Stereotaxis robotic magnetic navigation system
Stereotaxis (NYSE:STXS) announced today that a health provider in Kentucky performed the first procedures with its Genesis surgical robotic system. Physicians at Baptist Health Lexington successfully treated patients using the newest Stereotaxis advancement, the Genesis robotic magnetic navigation (RMN) system. Electrophysiologists at the same institution became the first to use RMN to treat patients all […]
